From July 1, 2023 to September 30, 2023, the company has repurchased 149,041 shares, representing 0.48% for $0.17 million. With this, the company has completed the repurchase of 4,708,520 shares, representing 14.3% for $15.42 million under the buyback announced on March 15, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +3.85% |
|
+8.00% | +1.50% |
Jul. 02 | Co-Diagnostics Expands Vector Control Customer Base | MT |
Jul. 02 | Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers Across 15 U.S. States | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.50% | 42.23M | |
-27.91% | 16.33B | |
-56.07% | 2.17B | |
+19.09% | 1.88B | |
-12.63% | 1.45B | |
+29.99% | 1.32B | |
+8.32% | 853M | |
-30.60% | 799M | |
-36.50% | 726M | |
+29.48% | 622M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Tranche Update on Co-Diagnostics, Inc.'s Equity Buyback Plan announced on March 15, 2022.